Journal of Controlled Release

ROS-responsive bionanodrug for atherosclerosis therapy via regulating glycolipid metabolism and cell crosstalk

By Jie Yu, Xiaoyan Dong, Feifei Yu, Yideng Jiang

Experiments in animalsInterventions

The paper

Jie Yu, Xiaoyan Dong, Feifei Yu, Yideng Jiang

Ningxia Medical University

Journal of Controlled Release, 17 Sep 2026

doi.org/10.1016/j.jconrel.2026.115362 PubMed 42753822

Advanced Materials9 Oct 2026
Self-renewing nanoparticles reduce friction and joint wear
Journal of Orthopaedic Translation5 Oct 2026
Low-intensity exercise eases age-related osteoarthritis in mice
International Immunopharmacology3 Oct 2026
Rapamycin improves efferocytosis and reduces plaques in mice
Advanced Materials2 Oct 2026
Bone-targeted exosomes delivering betaine reverse bone loss in osteoporotic rats